Company CVAbout FDC Ltd 
FDC Ltd
Mid Cap
Pharmaceuticals & Drugs
FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). FDC's formulation department designs and develops products for various global markets and the highly regulated markets of US and Europe. The company has built a visible presence in the Regulated and Emerging markets.
Company Coordinates
Company Details
B-8 MIDC Industrial Area, Waluj Dist Aurangabad (Maharashtra) Maharashtra : 431136
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 16.28 Cr
Number of Shares
16.28 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
09-Aug-2023
16.28
16.28
-3100000
1
Buy Back of Shares
12-May-2022
16.59
16.59
-2900000
1
Buy Back of Shares
08-Oct-2020
16.88
16.88
-2163000
1
Buy Back of Shares
24-Sep-2015
17.78
17.78
55385000
1
Amalgamation
24-Sep-2015
17.78
17.78
55385000
1
Amalgamation
23-Sep-2015
12.24
12.24
-55385000
1
Cancellation of Cross Holdings
23-Sep-2015
12.24
12.24
-55385000
1
Cancellation of Cross Holdings
13-Aug-2013
17.78
17.78
-9000
1
Buy Back of Shares
13-Aug-2013
17.78
17.78
-1000
1
Buy Back of Shares
13-Aug-2013
17.78
17.78
-9000
1
Buy Back of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 9 Schemes (5.87%)
FIIs
Held by 100 FIIs (2.67%)
Promoter with highest holding
Nomita R Chandavarkar (22.67%)
Highest Public shareholder
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund (2.61%)
Individual Investors Holdings
16.57%
Board of Directors
Management
Designation
Remuneration
Mohan A Chandavarkar
Managing Director
3.06 cr
Ashok A Chandavarkar
Director
1.63 cr
Nandan M Chandavarkar
Joint Managing Director
2.38 cr
Ameya A Chandavarkar
Executive Director & CEO
1.55 cr
Ramdas A Chandavarkar
Chairman Emeritus
0
Varsharani Katre
Company Sec. & Compli. Officer
0
Nomita R Chandavarkar
Director
64.91 lacs
Swati S Mayekar
Independent Director
3.55 lacs
Uday Kumar Gurkar
Chairman & Independent Directo
3.55 lacs
MELARKODE GANESAN PARAMESWARAN
Independent Director
2.75 lacs
Usha Athreya Chandrasekhar
Independent Director
2.75 lacs
Mahesh Bijlani
Independent Director
2.75 lacs
Vijay Maniar
Addtnl Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
464 Cr
(Quarterly Results - Dec 2024)
Net Profit:
37 Cr
Pharmaceuticals & Drugs
INR 6,923 Cr (Mid Cap)
24.00
33
1.23%
-0.25
13.81%
2.89
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
